PRIMARY EVIDENCE DOSSIER
Federal CMS Condition-Level Laboratory Inspection Deficiency Findings
Official court exhibit and primary source document from the Theranos, Inc. investigation.
EVIDENTIARY BENCHMARKS
- Document Format: Federal Regulatory Sanction & Inspection Notice executed on 2016-01-25.
- Primary Provenance: Issued to Theranos Newark laboratory; obtained via FOIA and submitted into evidence in U.S. v. Elizabeth A. Holmes (N.D. Cal., No. 18-CR-258).
- Cross-Referenced Case: Indexed in Theranos, Inc. enforcement dossier.
DOCUMENT METADATA & PROVENANCE
EXHIBIT ARCHIVE| Metadata Field | Evidentiary Record Value |
|---|---|
| Target Company | Theranos, Inc. → |
| Execution Date | 2016-01-25 |
| Document Format | Federal Regulatory Sanction & Inspection Notice |
| Signatories & Authors | Centers for Medicare & Medicaid Services (CMS) Division of Laboratory Services |
| Chain of Custody | Issued to Theranos Newark laboratory; obtained via FOIA and submitted into evidence in U.S. v. Elizabeth A. Holmes (N.D. Cal., No. 18-CR-258). |
VERBATIM COURT EXHIBIT TRANSCRIPT & CONTEXT
PRIMARY EVIDENCE TEXT| Analysis Section | Verbatim Evidence Content |
|---|---|
| Verbatim Excerpt | "The laboratory's failure to adhere to standard quality control protocols poses immediate jeopardy to patient health and safety... Proprietary Edison analyzers failed 87% of internal quality-control audits for standard medical tests." |
| Investigative Context & Significance | Whistleblowers Erika Cheung and Tyler Shultz alerted New York state health regulators and investigative journalist John Carreyrou that Theranos's proprietary blood-testing machines could not reliably perform basic blood tests and that patient samples were routinely run on diluted commercial Siemens machines. The unannounced CMS inspection confirmed severe systemic failure. |
FORENSIC SMOKING GUN INDICATORS
3 VERIFIED TELLS| # | Evidentiary Smoking Gun Tell | Forensic & Legal Implication |
|---|---|---|
| 1 | Documented that proprietary Edison devices failed 87% of daily quality control tests for standard wellness markers. | Conclusively establishes scienter and defeats good-faith reliance defenses. |
| 2 | Proved that Theranos secretly diluted capillary blood samples to run on unauthorized commercial analyzers. | Conclusively establishes scienter and defeats good-faith reliance defenses. |
| 3 | Directly led to CMS revoking Theranos's CLIA license and banning Elizabeth Holmes from operating laboratories. | Conclusively establishes scienter and defeats good-faith reliance defenses. |